Allergy and Immunology· Topic 1.1 Anaphylaxis· 1.1.7

Hymenoptera (insect sting) allergy

Hymenoptera sting allergy is an IgE-mediated reaction to venom from bees, wasps, hornets, and fire ants, ranging from large local reactions to systemic anaphylaxis. Systemic reactions are treated with intramuscular epinephrine, and venom immunotherapy is the disease-modifying treatment that reduces the risk of a future systemic sting reaction to about 5 percent.

5 min read3 practice questions7 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    Definition: Hymenoptera sting allergy is an IgE-mediated hypersensitivity to insect venom from bees, wasps, hornets, yellow jackets, and fire ants.

  • Epidemiology

    Common exposure, variable sensitization: stings are frequent, but systemic allergy affects a minority.

  • Risk factors

    Prior systemic sting reaction: the strongest predictor of future anaphylaxis.

  • Pathophysiology

    IgE sensitization: an initial sting sensitizes the patient, producing venom-specific IgE on mast cells.

  • Clinical features

    Normal local reaction: transient pain, swelling, and redness at the site.

  • Differential diagnosis

    Large local reaction versus cellulitis: immediate swelling peaking over 1 to 2 days suggests allergy, whereas warmth, fever, and spreading erythema over days suggest infection.

  • Diagnosis

    Establish with a systemic-reaction history plus venom sensitization testing: the diagnostic basis is a clinical history of a systemic sting reaction confirmed by a positive venom skin test or…

  • Management

    First, treat a systemic reaction as anaphylaxis: epinephrine 0.3 to 0.5 mg IM into the anterolateral thigh, repeated every 5 to 15 minutes, with oxygen, IV fluids, and airway support.

  • Complications

    Fatal anaphylaxis: the principal danger, especially in adults.

  • Prognosis

    Excellent with venom immunotherapy: the risk of a future systemic reaction falls to roughly 5 percent, and protection often persists after a completed course.

  • Prevention

    Venom immunotherapy for patients with a systemic reaction and confirmed sensitization, continued for 3 to 5 years, is the definitive preventive measure.

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.